XML 30 R18.htm IDEA: XBRL DOCUMENT v3.25.1
SHAREHOLDERS’ EQUITY
 3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
SHAREHOLDERS’ EQUITY

NOTE 9 – SHAREHOLDERS’ EQUITY

 

Common Stock

 

At the Company’s Annual Meeting of Shareholders held in July 2020, the Company approved the Restated 2014 Omnibus Long Term Incentive Plan (the “2014 LTIP”) in which the Company’s directors, officers, employees and consultants are eligible to participate. The 2014 LTIP terminated on September 3, 2024, and no future awards may be granted pursuant to the 2014 LTIP. Previously granted awards under the 2014 LTIP will remain outstanding until they expire by their terms or under the terms of the 2014 LTIP.

 

On June 12, 2024, the Company’s shareholders approved the 2024 Omnibus Long-Term Incentive Plan (the “2024 LTIP”), which went into effect upon shareholder approval. The maximum number of shares of the Company’s common stock that may be delivered pursuant to awards granted under the 2024 LTIP is 1,000,000, subject to increase by any awards under the 2014 LTIP (i) that were outstanding on or after June 12, 2024, and that, on or after such date, are forfeited, expire or are canceled, and (ii) any shares subject to awards relating to common stock under the 2014 LTIP that are settled in cash on or after June 12, 2024 (the “Prior LTIP Awards”). The 2024 LTIP also provides that, to the extent an award under the 2024 LTIP or a Prior LTIP Award is forfeited, expires or is canceled, in whole or in part, the shares subject to such forfeited, expired or canceled award may again be awarded under the 2024 LTIP. As of March 31, 2025, a total of 149,857 shares, net of forfeitures, had been issued under the 2024 LTIP and 850,280 were available for issuance under the 2024 LTIP.

 

Restricted Stock Awards

 

During the three months ended March 31, 2025, the Company issued restricted stock awards under the 2024 LTIP which are subject to certain vesting provisions and other terms and conditions set forth in each recipient’s respective restricted stock agreement. The Company issued 149,857 shares, net of forfeitures, under the 2024 LTIP, of restricted common stock to employees, directors, and certain advisors of the Company during the three months ended March 31, 2025. The fair value of these awards was $5,186,608 based on the closing price of the Company’s common stock on the respective grant dates, which will be recognized as compensation expense on a straight-line basis over the vesting period of the awards.

 

Share-based compensation expense of $1,304,904 and $803,386 was recognized in “Operating expenses” in the accompanying Consolidated Statements of Operations during the three months ended March 31, 2025 and 2024, respectively.

 

At March 31, 2025, there was $8,146,923 of total unrecognized share-based compensation expense related to unvested share-based equity awards. Unrecognized share-based compensation expense is expected to be recognized over a weighted-average period of 1.5 years.

 

 

Below is a summary of restricted stock activity for the three months ended March 31, 2025:

  

   Three Months Ended
March 31, 2025		 
   Shares  

Weighted Average

Grant Date Fair Value

 
Nonvested at beginning of period   202,787   $34.72 
Granted   152,589    34.64 
Vested   (62,151)   34.85 
Forfeited   (2,732)   36.13 
Nonvested at March 31, 2025   290,493   $34.90 

 

Stock Options

 

A summary of the status of outstanding stock options at March 31, 2025 and changes during the three months then ended is presented below:

  

  

Three Months Ended

March 31, 2025

     
   Options  

Weighted Average

Exercise

Price

  

Weighted Average

Remaining

Contract Life

  

Aggregate

Intrinsic

Value

 
Outstanding at beginning of period   31,013   $10.57           
Granted or assumed   -    -           
Exercised   -    -           
Forfeited   -    -           
Expired   -    -           
Outstanding at March 31, 2025   31,013   $10.57    5.6   $629,715.1 
                     
Exercisable at March 31, 2025   31,013   $10.57    5.6   $629,715.1